Selektive Herstellung einer Einzigen Axial Chiralen Verbindung
Anmelder: Astellas Pharma Inc. 🇯🇵
Details
- Veröffentlichungs-Nr.
- EP4775573
- Anmeldetag
- 6. September 2024
- Veröffentlichung
- 13. März 2025
- Rechtsraum
- EP
Abstract
The present invention, in one embodiment, relates to a method for producing a compound of formula (I) or a salt thereof, as defined in the specification. The production method includes reacting a compound of formula (IIA) or a salt thereof with a compound of formula (IIIA) or a salt thereof, or alternatively reacting a compound of formula (IIB) or a salt thereof with a compound of formula (IIIB) or a salt thereof, to obtain the compound of formula (I) or a salt thereof. In the compound of formula (I), it is preferred that R<4> is formula (VI) or (VII) and R<5> is formula (VIII) or (IX) (each of the formulas, together with R<4> and R<5>, is as defined in the specification).
Anmelder
- Firma
- Astellas Pharma Inc.
- Land
- 🇯🇵 Japan
Astellas Pharma ist ein japanisches Pharmaunternehmen mit Patenten zu Arzneimitteln, unter anderem in den Bereichen Onkologie, Urologie und Immunologie.
838 Patente in unserer Datenbank
Vertreten von
-
Potter Clarkson
Potter Clarkson · Copenhagen